Malaysia Sabah Hospital Special Strategy

First Overseas Benchmark Customer Strategic Blueprint

Strategic Positioning

The large-scale hospital in the Sabah region of Malaysia is Jianpei Technology's first potential customer in the Southeast Asian market, carrying significant strategic weight:

Strategic Value	Description
Benchmark Effect	A successful case will provide a replicable template for other SEA markets.
Model Validation	Validates the applicability of the Wuzhen "1+N" model in overseas markets.
Regional Reach	Sabah can serve as a hub for East Malaysia, Brunei, and the southern Philippines.

::: important Information Requested The following information is needed to further refine this strategy document:

1. Current IT/HIS system status of the hospital (survey of specific integration needs).
2. Priority departments/diseases (any specific areas in urgent need of AI empowerment).
3. Budget range and preferred cooperation models.
4. Details on local regulatory and compliance requirements (MDA registration status). :::

I. Sabah Market Background

1.1 Geography & Population

Item	Data
Location	East Malaysia, Northern Borneo
Population	Approx. 3.9 Million (2023)
Major Cities	Kota Kinabalu, Sandakan
Languages	Malay, English, Chinese

1.2 Healthcare Status & Challenges

Challenge	Description
Geographic Dispersion	Sabah covers approx. 74,000 sq km; primary resources struggle to reach remote areas.
Doctor Shortage	Doctor-to-population ratio is lower than in West Malaysia.
Digital Maturity	Relatively behind, but the government is actively pushing for digital transformation.

Wuzhen Model Applicability

The "Last Mile" medical issue in Sabah is similar to Wuzhen; the "1+N" model (Central Hospital + Smart Clinic Network) is highly applicable.

II. Priority Project: Hospital Universiti Malaysia Sabah (HUMS)

Hospital Universiti Malaysia Sabah (HUMS) is Jianpei Technology's most important entry point in Sabah. As the teaching hospital for Universiti Malaysia Sabah (UMS), it is defined as a Smart Teaching Hospital.

2.1 Basic Scale

Metric	Detailed Data	Note
Beds	400	Includes 40 ICU beds.
Specialist Clinics	145	Covers Internal Med, Surgery, Pediatrics, OBGYN, etc.
Operating Rooms	25	Equipped with advanced surgical facilities.
Day Care	58 beds	For day surgeries and short-term treatment.
Specialized Facilities	2 Angiogram rooms	Enhances cardiovascular intervention capabilities.

2.2 Phased Operational Plan (2026-2027)

HUMS will adopt a phased opening strategy:

Phase	Timeline	Key Tasks
Phase 0	2026.01 - 03	Migration & System Adjustment
Phase 1.1 (A)	2026.04	Initial operation of Specialist Clinics (PCC & TCU sites).
Phase 1.1 (B)	2026.07	Full move of Specialist Clinics into the HUMS Main Building.
Phase 1.2	2026.10	Launch of Day Care services and sharing of Operating Rooms.
Phase 1.3	2027.01	Inpatient services start; independent ORs fully operational.
Phase 1.4	2027.05	Women & Children services (OBGYN, Pediatrics) live.
Phase 1.5	2027.10	24/7 Emergency & Trauma services fully operational.

2.3 Priority Clinical Capabilities

• Radiology: Equipped with high-performance MRI and CT scanners; core scenario for AI image assistance.
• Cardiovascular: Angiogram rooms indicate high potential demand for AI coronary analysis (Digital Heart).
• Hemodialysis: 40 dialysis chairs serve as an entry point for chronic disease management and follow-up.
• Fully Digital Process: The emphasis on digital information systems facilitates rapid deployment of Digital Cloud Film and Cloud Imaging platforms.

III. Recommended Product Portfolio

A phased deployment strategy is recommended for the Sabah hospital:

Phase 1: Infrastructure (0-6 Months)

Product	Function	Value
Digital Cloud Film	Permanent data storage, color output	Resolves data silos; builds the foundation for AI.
Cloud Imaging Platform	Remote image transmission and access	Connects the central hospital with peripheral clinics.

Phase 2: AI-Assisted Diagnosis (6-12 Months)

Product	Function	Recommended Depts
Digital Lung	Lung nodule detection (99%+)	Pulmonology, Thoracic Surgery
Digital Heart	Coronary CTA analysis	Cardiology
AI Structured Reporting	Auto-generation, standardized terms	Radiology

Phase 3: Full-process Intelligent Healthcare (12-24 Months)

Product	Function	Business Model
Dr. Wood AI-CDSS	Full Prevention-Screening-Diagnosis-Rehab	SaaS Subscription or Pay-per-scan
Smart Patient Mgmt	Auto-follow-up, high-risk alerts	Value-added service
Smart Wearables	Remote health monitoring	Hardware + Service bundle

IV. Regulatory & Compliance Path

3.1 Malaysia MedDevice Regulation Overview

Item	Content
Regulator	MDA (Medical Device Authority)
Regulation	Medical Device Act 2012
Classification	Class A/B/C/D (AI-SaMD is typically Class B or C)
Timeline	Typically 6-12 Months

3.2 Key Compliance Requirements

Requirement	Description	Action Item
Local Auth. Rep (AR)	Appointment of a local AR is mandatory.	Partner with a firm in Sabah or West Malaysia.
Data Protection	Must comply with PDPA 2010.	Localized data storage solution.
Malay UI	UI should provide a Malay language option.	Product localization plan.

V. Business Model Recommendations

4.1 Pricing Strategy

Suggesting a consumption-driven model:

Model	Applicable Products	Advantage
SaaS Subscription	Dr. Wood AI-CDSS	Lower initial cost; rapid deployment.
Pay-per-scan	AI diagnosis	Aligned with volume; shared risk.
Hardware + Service	Smart Wearables	Hardware margin + recurring service revenue.

4.2 Value Quantization

Presenting metrics based on domestic experience:

Value Point	Metric
Efficiency Gain	Image reading efficiency up 20%+.
Diagnostic Accuracy	Lung nodule detection rate 99%+ (3mm+).
Service Experience	Experience with 230M+ cases.
Hospital Validations	Verified in 2000+ hospitals.

VI. Implementation Schedule

Phase	Hospital Operation Goal	Jianpei Delivery Goal	Timeline
Phase 0	Migration & System Adaptation	Environment Setup	2026 Q1
Phase 1	Specialist Clinics Open	Cloud Film & Imaging Platform	2026 Q1-Q2
Phase 2	Surgery & Inpatient Launch	AI Lung/Heart modules live	2026 Q3-Q4
Phase 3	Women/Children & 24/7 ER	Full AI-CDSS Application	2027

6.1 Schedule Visualization

gantt
    title Sabah Hospital Project Implementation Roadmap
    dateFormat YYYY-MM-DD
    section Hospital Operations
    Migration & Adj :2026-01-01, 90d
    Clinics Open    :2026-04-01, 180d
    Inpatient Launch:2026-10-01, 210d
    ER Services Live:2027-05-01, 180d


    section Jianpei Delivery
    In-depth Demand Survey  :a1, 2026-02-01, 60d
    MDA Reg. Preparation    :a2, 2026-02-01, 90d
    Local AR Appointment    :a3, 2026-04-01, 30d
    section Phase 1
    Cloud Film Deployment   :b1, 2026-04-01, 90d
    Cloud Imaging Integration:b2, 2026-07-01, 60d
    section Phase 2
    Digital Lung/Heart Live :c1, 2026-08-01, 90d
    Structured Reports Dept :c2, 2026-10-01, 90d
    section Phase 3
    Full AI-CDSS Go-live    :d1, 2026-10-01, 150d
    Smart Clinic Network Exp:d2, 2027-01-01, 180d

VII. Risks & Mitigations

Risk	Impact	Mitigation
MDA Reg. Delay	Project postponement	Start registration 6 months early; hire local consultants.
Language/Culture Barrier	Low user acceptance	Malay UI; localized training.
HIS Integration Hurdles	Data silos	Technical pre-assessment; standardized interfaces.
Competitor Pre-emption	Market share loss	Rapid PoC; establish first-mover advantage.

VIII. Next Actions

IMPORTANT

Please provide the following to deepen this strategy:

1. HIS/PACS system brands used by the hospital.
2. Budget range and preferred payment models.
3. Competitor intelligence: Are other firms currently in talks?
4. Decision cycle and expected go-live date.

Change History

Version	Date	Description	Author
1.0	2025-12-16	Initial Version: Special strategy framework for Sabah (HUMS).	Gemini
1.1	2025-12-18	Added detailed HUMS info and 2026-2027 timeline.	Gemini